The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus
Launched by SUN YAT-SEN MEMORIAL HOSPITAL OF SUN YAT-SEN UNIVERSITY · Jul 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called transcranial direct current stimulation (tDCS) for patients who have sudden deafness accompanied by tinnitus, which is a ringing or buzzing sound in the ears that isn’t caused by external noise. The goal of the study is to see if tDCS can effectively reduce the symptoms of tinnitus and improve hearing compared to traditional treatments. The trial will involve 86 patients, and those who qualify will receive tDCS therapy for five days. Researchers will assess the effectiveness of the treatment by asking participants to rate their tinnitus symptoms and hearing recovery throughout the study and will continue to follow them for up to six months after the treatment to see how well it works in the long run.
To be eligible for the trial, participants must be between 18 and 60 years old and must have experienced sudden deafness and tinnitus for less than a month without any prior drug treatment. They should feel sounds in their ears or head without any outside noise. However, patients with certain conditions, such as ear surgery history or specific types of tinnitus related to blood flow issues, are not eligible. Participants can expect to be part of a structured study that monitors their health closely, ensuring safety and compliance throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with tinnitus as the main complaint: patients subjectively feel sound in the ear or deep part of the head without internal or external sound stimulation, with or without hearing loss, and seek medical treatment
- • Patients with sudden deafness with tinnitus whose course is less than 1 month and have not received any drug treatment
- • Age 18-60 years
- • Tinnitus frequency is 125-8000 Hz
- Exclusion Criteria:
- • Patients with conductive deafness, history of middle ear surgery, pulsatile tinnitus caused by vascular aberration and tinnitus cause by Meniere disease
- • History of head trauma, central nervous system disease, mental disease, and drug abuse
About Sun Yat Sen Memorial Hospital Of Sun Yat Sen University
Sun Yat-sen Memorial Hospital of Sun Yat-sen University is a leading academic medical institution located in Guangzhou, China, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, including oncology, cardiology, and infectious diseases, to conduct rigorous studies aimed at improving treatment outcomes and enhancing patient welfare. With a focus on collaboration and scientific excellence, the hospital is dedicated to translating research findings into practical applications that benefit both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Yuexin Cai, Doctor
Principal Investigator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported